Gurus BioPharm is a biotech startup developing innovative drugs based on prostaglandin modification by Nitric Oxide donor. Our pipeline includes first-in-class molecules for these the indication: 1. Alopecia (passed pilot clinical trials)2. Asthma (ready for Phase I)3. COPD (ready for Phase I)4. Glaucoma (preclinical stage)5. COVID-19 vasculopathy (discovery stage)6. COVID-19 pneumonia (discovery stage)7. Coronavirus and flu (discovery stage)8. Cancer drug enhancer (discovery stage)9. Pulmonary arterial hypertension (discovery stage)10. Stroke (discovery stage)11. Erectile dysfunction (discovery stage)12. Critical Limb Ischemia (discovery stage)